Sun Pharma sees profit hit in FY16 on Ranbaxy integration

Last Updated: Monday, July 20, 2015, 21:50

Drug major Sun Pharma expects to take a hit on profit for the fiscal due to the charges related to the ongoing integration with Ranbaxy Laboratories.

Sun Pharma asks some Ranbaxy employees to leave, post merger

Last Updated: Thursday, June 18, 2015, 16:36

Sun Pharmaceutical Industries has started easing out excess employees from Ranbaxy, including senior executives, following completion of its USD 4 billion acquisition of the Gurgaon-based firm.

Sun Pharma asks 18 top brass of Ranbaxy to resign

Last Updated: Thursday, June 18, 2015, 12:23

This comes after a year after the Dilip Shanghvi-led firm acquired Ranbaxy in an all-stock deal and the company's Q4 profits shrank 44 per cent due to costs incurred in assimilating the buyout.

SPARC licenses Xelpros to Sun Pharma for US market

Last Updated: Tuesday, June 9, 2015, 23:25

Sun Pharma Advanced Research Company (SPARC) has licensed out Xelpros, a preservative-free eye drop, to a subsidiary of Sun Pharma for the US market.

Focus on getting Ranbaxy's plants USFDA nod one at a time: Sun Pharma

Last Updated: Sunday, June 7, 2015, 14:41

The Mumbai-based drug major, which acquired Ranbaxy in a USD 4 billion deal, feels it is important for the merged entity to "re-establish" the trust between Ranbaxy and the US Food and Drug Administration (USFDA).

Sun Pharma shareholders approve amalgamation scheme

Last Updated: Friday, June 5, 2015, 14:58

Sun Pharmaceutical on Friday said court convened meeting of its shareholders has approved the scheme of amalgamation of Sun Pharma Global Inc with itself.

Sun Pharma shares tank 9%; m-cap down Rs 20,864 cr post Q4 results

Last Updated: Monday, June 1, 2015, 18:19

Shares of Sun Pharmaceutical Industries plunged over 9 percent Monday, wiping out Rs 20,864 crore from its market valuation, after the company's fourth quarter earnings came below market expectations.

Sensex edges up ahead of RBI meet; Sun Pharma caps gains

Last Updated: Monday, June 1, 2015, 17:36

Sensex marginally rose by 20.55 Monday to 27,848.99 as consumer goods stocks gained on hopes that RBI would cut interest rates this week but a slump in Sun Pharma capped index's gains.

Sun Pharma shares tank 11%; top loser on Sensex, Nifty

Last Updated: Monday, June 1, 2015, 12:24

The stock plunged 11 percent to Rs 869.50 on the BSE. At the NSE, it dipped 10 percent to Rs 869.10.

Open to acquisitions but selective with targets: Sun Pharma

Last Updated: Sunday, May 31, 2015, 12:30

"We continue to remain opportunistic for acquisition... We are not looking at buying businesses where we have to spend a lot of time in managing," Sun Pharma MD Dilip Shanghvi said in an analyst call.

Plunging profits, lofty losses shadow India Inc Q4 report-card

Last Updated: Friday, May 29, 2015, 18:47

Defying the growth momentum in overall economy, corporate giants including M&M and Sun Pharma as well as state-run behemoths like NTPC, SAIL and IOC today announced lower quarterly profits, while many others have fared even worse due to rising costs and weak consumer demand.